September 16, 2015 | Ilex Medical, a leading Israeli medical device supplier, saw its share price rise at the announcement of a large tender in South Africa. The company reports that its South African sub-subsidiary has won a tender from the South African National Blood Service (SANBS) to replace existing blood testing mechanisms with those that can detect viruses. The value of the tender is estimated at $110 million. Ilex Medical is a publicly traded company on the Tel Aviv Stock Exchange and is headquartered in Israel.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024

Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024

BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments